NCT07868887

Brief Summary

This study aims to evaluate the practical and research utility of a new test assessing language and memory in people with MS. To this end, we are administering the test to a group of 100 individuals with MS who are receiving treatment at the National MS Center Melsbroek. These data will allow us to determine whether scores on the new test correlate with those of established cognitive tests. Subsequently, we will administer the new test to 100 individuals without an MS diagnosis who are matched for age, gender, and education level. This will enable us to assess whether there are significant differences in scores between individuals with MS and those without the diagnosis. One year later, we will re-administer the tests to the participants with MS to determine the extent to which changes in scores on the new test correspond to changes in scores on established tests.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
16mo left

Started Oct 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 5, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
10 days until next milestone

Study Start

First participant enrolled

October 19, 2026

Expected
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

October 9, 2026

Status Verified

September 1, 2026

Enrollment Period

1.3 years

First QC Date

October 5, 2026

Last Update Submit

October 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Language and Memory Test (LMT)

    The LMT is a brief multidomain test assessing finger tapping speed, rapid lexical access, and visuospatial memory, designed for MS populations.

    Baseline, after one week and and after one year

Other Outcomes (2)

  • Symbol Digit Modalities Test (SDMT)

    Baseline and after one year

  • Cognitive Change Scale (CCS)

    Baseline and after one year

Study Arms (2)

Adults diagnosed with multiple sclerosis

Treated in a the National MS Center rehabilitation center

Adults without MS diagnosis

matched for age, gender and educational level

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult people diagnosed with multiple sclerosis (PwMS), treated in a multidisciplinary rehabilitation program in the National Multiple Sclerosis Center (NMSC) Belgium. Healthy (no MS diagnosis) adults matched for age, gender and education

You may qualify if:

  • Native Dutch speaking
  • Sufficient visual function (capacity to perceive test stimuli)
  • Minimal single hand function to execute test responses
  • Cognitive capacity to apprehend test instructions

You may not qualify if:

  • Insufficient visual function (capacity to perceive test stimuli)
  • Inability to perform single-hand motor movements required to complete the test (e.g., tapping, selecting responses)
  • Insufficient cognitive capacity to understand or follow test instructions
  • For PwMS:
  • \- MS relapse more recently than three months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Leavitt VM, Simani L, Koch M, Morrow SA, Heuer L, Roozbeh M, Roozbeh M, Traynor S. The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis. Mult Scler. 2025 Oct;31(11):1348-1357. doi: 10.1177/13524585251366096. Epub 2025 Sep 25.

    PMID: 40995746BACKGROUND

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 5, 2026

First Posted

October 9, 2026

Study Start (Estimated)

October 19, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

October 9, 2026

Record last verified: 2026-09